Specific HIV-1 Reverse Transcriptase Inhibitors
- 1 January 1992
- journal article
- review article
- Published by Taylor & Francis in Journal of Enzyme Inhibition
- Vol. 6 (1) , 47-53
- https://doi.org/10.3109/14756369209041355
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase.Proceedings of the National Academy of Sciences, 1991
- An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives.Proceedings of the National Academy of Sciences, 1991
- A novel, dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding siteBiochemistry, 1991
- Human Immunodeficiency Virus Structure: Implications for Antiviral DesignPublished by Elsevier ,1991
- Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase InhibitorScience, 1990
- Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivativesNature, 1990
- Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivativeBiochemical and Biophysical Research Communications, 1989
- New acquisitions in the development of anti-HIV agentsAntiviral Research, 1989
- Genome organization and transactivation of the human immunodeficiency virus type 2Nature, 1987
- Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAVScience, 1986